Biomarin Pharmaceutical Inc
XBER:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XBER:BM8
|
US |
|
S
|
SoftBank Group Corp
F:SFTU
|
JP |
|
H
|
Hartford Financial Services Group Inc
SWB:HFF
|
US |
|
A
|
Altria Group Inc
BMV:MO
|
US |
|
C
|
Cintas Corp
XMUN:CIT
|
US |
|
M
|
Mercury General Corp
XMUN:MCG
|
US |
|
S
|
Sirius XM Holdings Inc
XETRA:RDO
|
US |
|
E
|
Endeavour Silver Corp
XMUN:EJD
|
CA |
|
B
|
British American Tobacco PLC
F:BMTA
|
UK |
|
D
|
Dow Inc
SWB:2OY
|
US |
|
Honda Motor Co Ltd
F:HDM
|
JP |
|
E
|
Enbridge Inc
F:EN3
|
CA |
|
V
|
Varonis Systems Inc
F:VS2
|
US |
|
V
|
Varonis Systems Inc
SWB:VS2
|
US |
|
A
|
Aspen Pharmacare Holdings Ltd
SWB:LDZA
|
ZA |
|
N
|
Northrop Grumman Corp
DUS:NTH
|
US |
|
M
|
Mondi PLC
OTC:MNODF
|
UK |
|
F
|
FedEx Corp
BMV:FDX
|
US |
Shareholder Yield
Current shareholder yield for 
BM8 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BM8 Price
Biomarin Pharmaceutical Inc
| Average Annual Return | 2.23% |
| Standard Deviation of Annual Returns | 24.93% |
| Max Drawdown | -59% |
| Market Capitalization | 10.4B EUR |
| Shares Outstanding | 183 590 000 |
| Percentage of Shares Shorted |
N/A
|
